Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4-20.
Rachaneni S, Latthe P. Does preoperative urodynamics improve outcomes for women undergoing surgery for stress urinary incontinence? A systematic review and meta-analysis. BJOG. 2015;122:8-16.
Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2015;(7):CD006375.
1. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4-20.
2. Sgadari A, Topinkovaa E, Bjornson J, et al. Urinary incontinence in nursing home residents: a cross-national comparison. Age Ageing. 1997;26:49-54.
3. Grodstein F, Fretts R, Lifford K, et al. Association of age, race, and obstetric history with urinary symptoms among women in the Nurses' Health Study. Am J Obstet Gynecol. 2003;189:428-434.
4. Sampselle CM, Harlow SD, Skurnick J, et al. Urinary incontinence predictors and life impact in ethnically diverse perimenopausal women. Obstet Gynecol. 2002;100:1230-1238.
5. Nygaard I, Turvey C, Burns TL, et al. Urinary incontinence and depression in middle-aged United States women. Obstet Gynecol. 2003;101:149-156.
6. Anger JT, Saigal CS, Litwin MS, et al. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol. 2006;175:601-604.
7. Hannestad YS, Rortveit G, Sadvik H, et al. A community-based epidemiologic survey of female urinary incontinence. The Norwegian EPICONT Study. J Clin Epidemiol. 2000;53:1150-1157.
8. Abrams P, Cardozo L, Khoury S, et al (eds); European Association of Urology; International Consultation on Urological Diseases. Incontinence. Fifth International Consultation on Incontinence, Paris. February 2013. http://www.icud.info/incontinence.html (last accessed 12 October 2016).
9. Wilson L, Park GE, Luc KO, et al. Annual direct costs of urinary incontinence. Obstet Gynecol. 2001;98:398-406.
10. Subak LL, Brown JS, Kraus SR, et al. The "costs" of urinary incontinence for women. Obstet Gynecol. 2006;107:908-916.
11. Burgio KL, Locher JL, Zycznski H, et al. Urinary incontinence during pregnancy in a racially mixed sample: characteristics and predisposing factors. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7:69-73.
12. Viktrup L, Lose G, Rolff M, et al. The symptom of stress incontinence caused by pregnancy or delivery in primiparas. Obstet Gynecol. 1992;79:945-949.
13. Alling Moller L, Lose G, Jergensen T. Risk factors for lower urinary tract symptoms in women 40-60 years of age. Obstet Gynecol. 2000;96:446-451.
14. Handa VL, Harris TA, Ostergard DR. Protecting the pelvic floor: obstetric management to prevent incontinence and pelvic organ prolapse. Obstet Gynecol. 1996;88:470-478.
15. Deffieux X. Urinary incontinence and pregnancy [in French]. J Gynecol Obstet Biol Reprod. 2009;38(8 Suppl):S212-S231.
16. Burgio KL, Mathews KA, Engel BT. Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol. 1991;146:1255-1259.
17. Dwyer PL, Lee ET, Hat DM. Obesity and urinary incontinence in women. Br J Obstet Gynaecol. 1988;95:91-96.
18. Diokno AC, Brock BM, Brown MB, et al. Prevalence of urinary incontinence and other urologic symptoms in the non-institutionalized elderly. J Urol. 1986;136:1022-1025.
19. Skelly J, Flint AJ. Urinary incontinence associated dementia. Am J Geriatr Soc. 1995;43:286-294.
20. Nygaard IE, Thompson FL, Svegalis SL, et al. Urinary incontinence in elite nulliparous athletes. Obstet Gynecol. 1994;84:183-187.
21. Nygaard I, Delancy JO, Arnsdorf L, et al. Exercise and incontinence. Obstet Gynecol. 1990;75:848-851.
22. Bent AE, Ostergard DR, Cundiff GW, et al. Urogynecology and pelvic floor dysfunction: pathophysiology. Philadelphia, PA: Lippincott, Williams & Wilkins; 2003.
23. Chiarelli P, Brown W, McElduff P. Leaking urine: prevalence and associated factors in Australian women. Neurourol Urodyn. 1999;18:567-577.
24. Maggi S, Minicuci N, Langlois J, et al. Prevalence rate of urinary incontinence in community-dwelling elderly individuals: the Veneto study. J Gerontol A Biol Sci Med Sci. 2001;56:M14-M18.
25. Buchsbaum GM, Chin M, Glantz C, et al. Prevalence of urinary incontinence and associated risk factors in a cohort of nuns. Obstet Gynecol. 2002;100:226-229.
26. Thom DH, Haan MN, Van den Eeden SK. Medically recognized urinary incontinence and risk of hospitalization, nursing home admission and mortality. Age Ageing. 1997;26:367-374.
27. Shin DC, Shin SH, Lee MM, et al. Pelvic floor muscle training for urinary incontinence in female stroke patients: a randomized, controlled and blinded trial. Clin Rehabil. 2016;30:259-267.
28. Swash M, Snooks SJ, Chalmes DH. Parity as a factor in incontinence in Multiple Sclerosis. Arch Neurol. 1987;44:504-508.
29. Andrews J, Nathan P. Lesions of the anterior frontal lobes and disturbances of micturition and defecation. Brain. 1964;87:233-262.
30. Arya LA, Myers DL, Jackson ND. Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet Gynecol. 2000;96:85-89.
31. Montella J, Wordell CJ. The effects of drugs on the lower urinary tract. In: Ostergard D, Bent A, eds. Urogynecology and urodynamics. Baltimore, MD: Williams and Wilkins, 1996.
32. Movig KL, Leufkens HG, Belitser SV, et al. Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Saf. 2002;11:271-279.
33. Huggins ME, Ostergard DR. Pathophysiology of urinary incontinence. In: Ghoneim G, Davila GW, eds. Practical guide to female pelvic medicine. Oxford, UK: Taylor & Francis, 2006.
34. Nygaard IE, Lemke JH. Urinary incontinence in rural older women: prevalence, incidence and remission. J Am Geriatr Soc. 1996;44:1049-1054.
35. Landi F, Cesari M, Russo A, et al. Potentially reversible risk factors and urinary incontinence in frail older people living in community. Age Ageing. 2003;32:194-199.
36. Nelson R, Furner S, Jesudason V. Urinary incontinence in Wisconsin skilled nursing facilities: prevalence and association in common with fecal incontinence. J Aging Health. 2001;13:539-547.
37. Ouslander JG, Schnelle JF. Incontinence in the nursing home. Ann Intern Med. 1995;122:438-449.
38. Palmer MH, German PS, Ouslander JG. Risk factors for urinary incontinence one year after nursing home admission. Res Nurs Health. 1991;14:405-412.
39. Rohr G, Kragstrup J, Gaist D, et al. Genetic and environmental influences on urinary incontinence: a Danish population-based twin study of middle-aged and elderly women. Acta Obstet Gynecol Scand. 2004;83:978-982.
40. Mushkat Y, Bukovsky I, Langer R. Female urinary stress incontinence - does it have familial prevalence? Am J Obstet Gynecol. 1996;174:617-619.
41. Hannestad YS, Lie RT, Rortveit G, et al. Familial risk of urinary incontinence in women: population-based cross sectional study. BMJ. 2004; 329:889-891.
42. Swithinbank LV, Brookes ST, Shepherd RB, et al. The natural history of urinary symptoms during adolescence. Br J Urol. 1998;81:90(suppl 3):90-93.
43. Kuh D, Cardozo L, Hardy R. Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J Epidem Community Health. 1999;53:453-458.
44. Bump RC, McClish DK. Cigarette smoking and urinary incontinence in women. Am J Obstet Gynecol. 1992;167:1213-1218.
45. Brown JS, Sawaya G, Thom DH, et al. Hysterectomy and urinary incontinence: a systematic review. Lancet. 2000;356:535-539.
46. Parkin DE, Davis JA, Symonds RP. Urodynamic findings following radiotherapy for cervical carcinoma. Br J Urol. 1988;61:213-217.
47. Martin JL, Williams KS, Sutton AJ, et al. Systematic review and meta-analysis of methods of diagnostic assessment for urinary incontinence. Neurourol Urodyn. 2006;25:674-683.
48. Wyman JF, Choi SC, Harkins SW, et al. The urinary diary in evaluation of urinary incontinence in women: a test retest analysis. Obstet Gynecol. 1988;71:812-817.
49. Ghoniem G, Stanford E, Kenton K, et al. Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:5-33.
50. Abrams P, Cardozo L, Khoury S, et al (eds). Symptom and quality of life assessment. Incontinence volume 1: basics and evaluation. Third International Consultation on Incontinence, June 26-29, 2004. International Continence Society/Société Internationale d'Urologie. Paris: Editions 21; 2005.
51. Borrie MJ, Campbell K, Arcese ZA, et al. Urinary retention in patients in a geriatric rehabilitation unit; prevalence, risk factors and validity of bladder scan. Rehabil Nurs. 2001;5:187-191.
52. Nager CW, Brubaker L, Litman HJ, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med. 2012;366:1987-1997.
53. Rachaneni S, Latthe P. Does preoperative urodynamics improve outcomes for women undergoing surgery for stress urinary incontinence? A systematic review and meta-analysis. BJOG. 2015;122:8-16.
54. Committee on Practice Bulletins - Gynecology and the American Urogynecologic Society. ACOG Practice Bulletin no. 155: urinary incontinence in women. Obstet Gynecol. 2015;126:e66-e81.
55. Subak LL, Wing R, West DS, et al; PRIDE Investigators. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360:481-490.
56. Subak LL, Richter HE, Hunskaar S. Obesity and urinary incontinence: epidemiology and clinical research update. J Urol. 2009;182(suppl):S2-S7.
57. Wing RR, Creasman JM, West DS, et al. Improving urinary incontinence in overweight and obese women through modest weight loss. Obstet Gynecol. 2010;116:284-292.
58. Dumoulin C, Hay-Smith EJ, Mac Habée-Séguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2014;(5):CD005654.
59. Wilson PD, Bo K, Hay-Smith J, et al. Conservative treatment in women. Incontinence. Plymouth, UK: Plymbridge Distributors Ltd; 2002:571-624.
60. Thakar R, Stanton S. Regular review; management of urinary incontinence in women. BMJ. 2000;321:1326-1331.
61. Fantl JA, Wyman JF, McClish DK,et al. Efficacy of bladder training in older women with urinary incontinence. JAMA. 1991;265:609-613.
62. Fantl JA, Hurt WG, Dunn LJ. Detrusor instability syndrome: the use of bladder retraining drills with and without anticholinergics. Am J Obstet Gynecol. 1981;140:885-890.
63. National Institute for Health and Care Excellence. Urinary incontinence in women: management. September 2013. http://www.nice.org.uk/ (last accessed 12 October 2016).
64. Burgio KL, Kraus SR, Menefee S, et al; Urinary Incontinence Treatment Network. Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial. Ann Intern Med. 2008;149:161-169.
65. Qaseem A, Dallas P, Forciea MA, et al. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161:429-440.
66. Keating JC, Schulte EA, Miller E. Conservative care of urinary incontinence in the elderly. J Manipulative Physiol Ther. 1988;14:300-308.
67. Nygaard I, Heit M. Stress urinary incontinence. Obstet Gynecol. 2004;104:607-620.
68. Robert M, Mainprize TC. Long-term assessment of the incontinence ring pessary for the treatment of stress incontinence. Int Urogynecol J. 2002;13:326-329.
69. Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2010;115:609-617.
70. Cardozo LD. Biofeedback in overactive bladder. Urology. 2000;55:24-28.
71. Herderschee R, Hay-Smith EJ, Herbison GP, et al. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2011;(7):CD009252.
72. Burgio KL, Goode PS, Locher JL, et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. JAMA. 2002;288:2293-2299.
73. Dumoulin C, Hay-Smith EJ, Mac Habée-Séguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2014;(5):CD005654.
74. Barroso JC, Ramos JG, Martins-Costa S, et al. Transvaginal electrical stimulation in the treatment of urinary incontinence. BJU Int. 2004; 93:319-323.
75. Hartmann KE, McPheeters ML, Biller DH, et al. Treatment of overactive bladder in women. Evid Rep Technol Assess. 2009;1-120.
76. Nitti VW, Dmochowski R, Herschorn S, et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013;189:2186-2193.
77. Abrams P, Kelleher C, Staskin D, et al. Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony). Eur Urol. 2015;67:577-588.
78. Agency for Healthcare Policy and Research. Urinary incontinence in adults: acute and chronic management. Rockville, MD: Agency for Health Care Policy and Research (AHCPR); 1996.
79. Cardozo L, Lange R, Voss S, et al. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence. Curr Med Res Opin. 2010;26:253-261.
80. Cody JD, Jacobs ML, Richardson K, et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;(10):CD001405.
81. Lapitan MC, Cody JD. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2016;(2):CD002912.
82. Nilsson CG, Palva K, Aarnio R, et al. Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J. 2013;24:1265-1269.
83. Amrute KV, Badlani GH. Female incontinence: a review of biomaterials and minimally invasive techniques. Curr Opin Urol. 2006;16:54-59.
84. Ho MH, Lin LL, Haessler AL, et al. Tension-free transobturator tape procedure for stress urinary incontinence. Curr Opin Obstet Gynecol. 2006;18:567-574.
85. Latthe PM. Review of transobturator and retropubic tape procedures for stress urinary incontinence. Curr Opin Obstet Gynecol. 2008;20:331-336.
86. Latthe PM, Foon R, Toozs-Hobson P. Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG. 2007;114:522-531. [Erratum in: BJOG. 2007;114:1311.]
87. Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2015;(7):CD006375.
88. Palva KR, Rinne K, Aukee P, et al. A randomized trial comparing tension-free vaginal tape with tension-free vaginal tape-obturator: 36-month results. Int Urogynecol J Pelvic Floor Dysfunct. 2010;21:1049-1055.
89. Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362:2066-2076.
90. Nilsson CG, Palva K, Rezapour M, et al. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1043-1047.
91. Albo ME, Litman HJ, Richter HE, et al. Treatment success of retropubic and transobturator mid urethral slings at 24 months. J Urol. 2012;188:2281-2287.
92. Schimpf MO, Rahn DD, Wheeler TL, et al; Society of Gynecologic Surgeons Systematic Review Group. Sling surgery for stress urinary incontinence in women: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014;211:71.e1-71.e27.
93. Barber MD, Weidner AC, Sokol AI, et al. Single-incision mini-sling compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2012;119:328-337.
94. Lee JK, Rosamilia A, Dwyer PL, et al. Randomized trial of a single incision versus an outside-in transobturator midurethral sling in women with stress urinary incontinence: 12 month results. Am J Obstet Gynecol. 2015;213:35.e1-35.e9.
95. van der Ploeg JM, Oude Rengerink K, van der Steen A, et al; Dutch Urogynaecology Consortium. Transvaginal prolapse repair with or without the addition of a midurethral sling in women with genital prolapse and stress urinary incontinence: a randomised trial. BJOG. 2015;122:1022-1030.
96. Long CY, Hsu CS, Wu MP, et al. Comparison of tension-free vaginal tape and transobturator tape procedure for the treatment of stress urinary incontinence. Curr Opin Obstet Gynecol. 2009;21:342-347.
97. Latthe PM, Singh P, Foon R, et al. Two routes of transobturator tape procedures in stress urinary incontinence: a meta-analysis with direct and indirect comparison of randomized trials. BJU Int. 2010;106:68-76.
98. Guerette NL, Bena JF, Davila GW. Transobturator slings for stress incontinence: using urodynamic parameters to predict outcomes. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:97-102.
99. Ghoniem GM, Miller CJ. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J. 2013;24:27-36.
100. Ghoniem G, Corcos J, Comiter C, et al. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. J Urol. 2009;181:204-210.
101. Govier FE, Litwiller S, Nitti V, et al. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165:1193-1198.
102. Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183:1438-1443.
103. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178:2029-2034.
104. Sahai A, Khan MS, Dasgupta P. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single centre, randomized double blind placebo controlled trial. J Urol. 2007;6:2231-2236.
105. Werner M, Schmid DM, Schuller B. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective non-randomized study. Am J Obstet Gynecol. 2005;5:1735-1740.
106. Cruz F, Herschorn S, Aliotta P, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2011;60:742-750.
107. Sievert KD, Chapple C, Herschorn S, et al. OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder. Int J Clin Pract. 2014;68:1246-1256.
108. Lipp A, Shaw C, Glavind K. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev. 2014;(12):CD001756.
109. Abdel-fattah M, Mostafa A, Young D, et al. Evaluation of transobturator tension-free vaginal tapes in the management of women with mixed urinary incontinence: one-year outcomes. Am J Obstet Gynecol. 2011;205:150.e1-150.e6.
110. Pradhan A, Jain P, Latthe PM. Effectiveness of midurethral slings in recurrent stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2012;23:831-841.
111. Sand PK, Davila GW, Lucente VR, et al. Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome. Am J Obstet Gynecol. 2012;206:168.
112. Peters KM, Carrico DJ, Wooldridge LS, et al. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189:2194-2201.
113. Visco AG, Brubaker L, Richter HE, et al. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med. 2012;367:1803-1813.
114. Jain P, Jirschele K, Botros SM, et al. Effectiveness of midurethral slings in mixed urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2011;22:923-932.
115. Grimby A, Milson I, Molander U, et al. The influence of urinary incontinence on the quality of life of elderly women. Age Ageing. 1993;2:82-89.
116. Noelker LS. Incontinence in elderly cared for by family. Gerontologist. 1987;2:194-200.
117. Walters MD, Daneshgari F. Surgical management of stress urinary incontinence. Clin Obstet Gynecol. 2004;47:93-103.
118. Sung VW, Schleinitz MD, Rardin CR, et al. Comparison of retropubic vs transobturator approach to midurethral slings: a systematic review and meta-analysis. Am J Obs Gyn. 2007;197:3-11.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台